Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis.
Target Oncol. 2016 Apr;11(2):143-8. doi: 10.1007/s11523-015-0392-7.
Target Oncol. 2016.
PMID: 26429561
Review.
Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity.
Porta C, Giglione P, Liguigli W, Paglino C.
Porta C, et al. Among authors: giglione p.
Future Oncol. 2015;11(1):39-50. doi: 10.2217/fon.14.208.
Future Oncol. 2015.
PMID: 25572783
Item in Clipboard
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
Porta C, Giglione P, Paglino C.
Porta C, et al. Among authors: giglione p.
Expert Opin Pharmacother. 2016;17(5):643-55. doi: 10.1517/14656566.2016.1127353. Epub 2016 Jan 6.
Expert Opin Pharmacother. 2016.
PMID: 26630127
Review.
Item in Clipboard
Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
Grassi P, Doucet L, Giglione P, Grünwald V, Melichar B, Galli L, De Giorgi U, Sabbatini R, Ortega C, Santoni M, Bamias A, Verzoni E, Derosa L, Studentova H, Pacifici M, Coppa J, Mazzaferro V, de Braud F, Porta C, Escudier B, Procopio G.
Grassi P, et al. Among authors: giglione p.
PLoS One. 2016 Apr 11;11(4):e0151662. doi: 10.1371/journal.pone.0151662. eCollection 2016.
PLoS One. 2016.
PMID: 27064898
Free PMC article.
Item in Clipboard
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents.
Grassi P, Doucet L, Giglione P, Grünwald V, Melichar B, Galli L, De Giorgi U, Sabbatini R, Ortega C, Santoni M, Bamias A, Verzoni E, Derosa L, Studentova H, Porcu L, De Braud F, Porta C, Procopio G.
Grassi P, et al. Among authors: giglione p.
Oncology. 2017;92(5):269-275. doi: 10.1159/000455970. Epub 2017 Feb 17.
Oncology. 2017.
PMID: 28208153
Item in Clipboard
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma].
Giglione P, Lombardo F, Toscani I, Paglino C, Porta C.
Giglione P, et al.
Recenti Prog Med. 2015 Aug;106(8):370-9. doi: 10.1701/1960.21302.
Recenti Prog Med. 2015.
PMID: 26228864
Review.
Italian.
Item in Clipboard
Tivantinib (ARQ197) in hepatocellular carcinoma.
Porta C, Giglione P, Ferrari A, Reversi F, Liguigli W, Imarisio I, Ganini C.
Porta C, et al. Among authors: giglione p.
Expert Rev Anticancer Ther. 2015 Jun;15(6):615-22. doi: 10.1586/14737140.2015.1050383.
Expert Rev Anticancer Ther. 2015.
PMID: 26035719
Review.
Item in Clipboard
Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study.
Bruzzone M, Centurioni MG, Giglione P, Gualco M, Merlo DF, Miglietta L, Cosso M, Giannelli F, Cristoforoni P, Ferrarini M.
Bruzzone M, et al. Among authors: giglione p.
Oncology. 2011;80(3-4):238-46. doi: 10.1159/000328451. Epub 2011 Jul 5.
Oncology. 2011.
PMID: 21734415
Clinical Trial.
Item in Clipboard
Cite
Cite